Filed: 2/14/2025ACC: 0001920938-25-000002
📋 What this filing means
BRAIDWELL LP filed this quarterly 13F‑HR report disclosing 73 equity positions with a total reported market value of $3.37B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
73
Positions
$3.37B
Total AUM (reported)
1.37B
Total Shares
Allocation by class
COM$1.69B50.0%
NOTE11/1$226.00M6.7%
COM NEW$156.02M4.6%
NOTE 2.500% 3/1$148.15M4.4%
NOTE11/0$134.50M4.0%
SPONSORED ADS$132.21M3.9%
NOTE 1.000%12/1$114.80M3.4%
Portfolio Concentration
Top 3$508.65M15.1%
4–10$754.67M22.4%
11–25$1.00B29.8%
Rest$1.11B32.8%
Top 3 weight
15.1%
Top 10 weight
37.5%
Voting Authority Distribution
Total shares with voting rights: 1.37B
Sole
Full voting authority
1.37B
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole73
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings73
Rows:
GUARDANT HEALTH INC
SOLEShares268.25M
TypePRN
Market value$226.00M
6.70%
Sole
268.25M
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares140.84M
TypePRN
Market value$148.15M
4.39%
Sole
140.84M
Shared
0.00
None
0.00
NOVOCURE LTD
SOLEShares140.83M
TypePRN
Market value$134.50M
3.99%
Sole
140.83M
Shared
0.00
None
0.00
NEUROCRINE BIOSCIENCES INC
SOLEShares901.79K
TypeSH
Market value$123.09M
3.65%
Sole
901.79K
Shared
0.00
None
0.00
REPLIGEN CORP
SOLEShares112M
TypePRN
Market value$114.80M
3.40%
Sole
112M
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares2.91M
TypeSH
Market value$114.23M
3.39%
Sole
2.91M
Shared
0.00
None
0.00
NUVASIVE INC
SOLEShares114.21M
TypePRN
Market value$113.21M
3.36%
Sole
114.21M
Shared
0.00
None
0.00
NEOGENOMICS INC
SOLEShares116.38M
TypePRN
Market value$98.27M
2.91%
Sole
116.38M
Shared
0.00
None
0.00
LEGEND BIOTECH CORP
SOLEShares2.98M
TypeSH
Market value$96.90M
2.87%
Sole
2.98M
Shared
0.00
None
0.00
CG ONCOLOGY INC
SOLEShares3.28M
TypeSH
Market value$94.17M
2.79%
Sole
3.28M
Shared
0.00
None
0.00
GUARDANT HEALTH INC
SOLEShares2.85M
TypeSH
Market value$87.00M
2.58%
Sole
2.85M
Shared
0.00
None
0.00
IRONWOOD PHARMACEUTICALS INC
SOLEShares92.74M
TypePRN
Market value$85.21M
2.53%
Sole
92.74M
Shared
0.00
None
0.00
ALIGN TECHNOLOGY INC
SOLEShares375.18K
TypeSH
Market value$78.23M
2.32%
Sole
375.18K
Shared
0.00
None
0.00
DEXCOM INC
SOLEShares82.70M
TypePRN
Market value$74.38M
2.21%
Sole
82.70M
Shared
0.00
None
0.00
APOGEE THERAPEUTICS INC
SOLEShares1.54M
TypeSH
Market value$69.78M
2.07%
Sole
1.54M
Shared
0.00
None
0.00
KINIKSA PHARMACEUTICALS INTL
SOLEShares3.45M
TypeSH
Market value$68.29M
2.02%
Sole
3.45M
Shared
0.00
None
0.00
APELLIS PHARMACEUTICALS INC
SOLEShares2.10M
TypeSH
Market value$66.97M
1.99%
Sole
2.10M
Shared
0.00
None
0.00
IRHYTHM TECHNOLOGIES INC
SOLEShares705.39K
TypeSH
Market value$63.61M
1.89%
Sole
705.39K
Shared
0.00
None
0.00
EDGEWISE THERAPEUTICS INC
SOLEShares2.33M
TypeSH
Market value$62.27M
1.85%
Sole
2.33M
Shared
0.00
None
0.00
DAY ONE BIOPHARMACEUTICALS I
SOLEShares4.87M
TypeSH
Market value$61.75M
1.83%
Sole
4.87M
Shared
0.00
None
0.00
SPYRE THERAPEUTICS INC
SOLEShares2.58M
TypeSH
Market value$60.03M
1.78%
Sole
2.58M
Shared
0.00
None
0.00
VIKING THERAPEUTICS INC
SOLEShares1.48M
TypeSH
Market value$59.54M
1.77%
Sole
1.48M
Shared
0.00
None
0.00
TRANSMEDICS GROUP INC
SOLEShares922.10K
TypeSH
Market value$57.49M
1.70%
Sole
922.10K
Shared
0.00
None
0.00
ALPHATEC HLDGS INC
SOLEShares58.22M
TypePRN
Market value$55.09M
1.63%
Sole
58.22M
Shared
0.00
None
0.00
INSPIRE MED SYS INC
SOLEShares293.41K
TypeSH
Market value$54.39M
1.61%
Sole
293.41K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
GUARDANT HEALTH INCSOLE | NOTE11/1 | 268.25M | PRN | $226.00M 6.70% | 268.25M | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | NOTE 2.500% 3/1 | 140.84M | PRN | $148.15M 4.39% | 140.84M | 0.00 | 0.00 |
NOVOCURE LTDSOLE | NOTE11/0 | 140.83M | PRN | $134.50M 3.99% | 140.83M | 0.00 | 0.00 |
NEUROCRINE BIOSCIENCES INCSOLE | COM | 901.79K | SH | $123.09M 3.65% | 901.79K | 0.00 | 0.00 |
REPLIGEN CORPSOLE | NOTE 1.000%12/1 | 112M | PRN | $114.80M 3.40% | 112M | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 2.91M | SH | $114.23M 3.39% | 2.91M | 0.00 | 0.00 |
NUVASIVE INCSOLE | NOTE 0.375% 3/1 | 114.21M | PRN | $113.21M 3.36% | 114.21M | 0.00 | 0.00 |
NEOGENOMICS INCSOLE | NOTE 0.250% 1/1 | 116.38M | PRN | $98.27M 2.91% | 116.38M | 0.00 | 0.00 |
LEGEND BIOTECH CORPSOLE | SPONSORED ADS | 2.98M | SH | $96.90M 2.87% | 2.98M | 0.00 | 0.00 |
CG ONCOLOGY INCSOLE | COM | 3.28M | SH | $94.17M 2.79% | 3.28M | 0.00 | 0.00 |
GUARDANT HEALTH INCSOLE | COM | 2.85M | SH | $87.00M 2.58% | 2.85M | 0.00 | 0.00 |
IRONWOOD PHARMACEUTICALS INCSOLE | NOTE 1.500% 6/1 | 92.74M | PRN | $85.21M 2.53% | 92.74M | 0.00 | 0.00 |
ALIGN TECHNOLOGY INCSOLE | COM | 375.18K | SH | $78.23M 2.32% | 375.18K | 0.00 | 0.00 |
DEXCOM INCSOLE | NOTE 0.375% 5/1 | 82.70M | PRN | $74.38M 2.21% | 82.70M | 0.00 | 0.00 |
APOGEE THERAPEUTICS INCSOLE | COM | 1.54M | SH | $69.78M 2.07% | 1.54M | 0.00 | 0.00 |
KINIKSA PHARMACEUTICALS INTLSOLE | ORD SHS CL A | 3.45M | SH | $68.29M 2.02% | 3.45M | 0.00 | 0.00 |
APELLIS PHARMACEUTICALS INCSOLE | COM | 2.10M | SH | $66.97M 1.99% | 2.10M | 0.00 | 0.00 |
IRHYTHM TECHNOLOGIES INCSOLE | COM | 705.39K | SH | $63.61M 1.89% | 705.39K | 0.00 | 0.00 |
EDGEWISE THERAPEUTICS INCSOLE | COM | 2.33M | SH | $62.27M 1.85% | 2.33M | 0.00 | 0.00 |
DAY ONE BIOPHARMACEUTICALS ISOLE | COM | 4.87M | SH | $61.75M 1.83% | 4.87M | 0.00 | 0.00 |
SPYRE THERAPEUTICS INCSOLE | COM NEW | 2.58M | SH | $60.03M 1.78% | 2.58M | 0.00 | 0.00 |
VIKING THERAPEUTICS INCSOLE | COM | 1.48M | SH | $59.54M 1.77% | 1.48M | 0.00 | 0.00 |
TRANSMEDICS GROUP INCSOLE | COM | 922.10K | SH | $57.49M 1.70% | 922.10K | 0.00 | 0.00 |
ALPHATEC HLDGS INCSOLE | NOTE 0.750% 8/0 | 58.22M | PRN | $55.09M 1.63% | 58.22M | 0.00 | 0.00 |
INSPIRE MED SYS INCSOLE | COM | 293.41K | SH | $54.39M 1.61% | 293.41K | 0.00 | 0.00 |
Page 1 of 3